Profile
MNMD NVO VRTX REGN SGEN ALNY
Company Name Mind Medicine (MindMed) Inc. Novo Nordisk A/S Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Seagen Inc. Alnylam Pharmaceuticals, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $472.99M $498.51B $122.62B $100.05B $43.15B $36.14B
Employees 0.06K 69.26K 5.40K 13.93K 3.26K 2.10K
CEO Mr. Robert Barrow Mr. Lars Fruergaard Jorgensen Dr. Reshma Kewalramani FASN, M.D. Dr. Leonard S. Schleifer M.D., Ph.D. Mr. David R. Epstein B.Sc., M.B.A. Dr. Yvonne L. Greenstreet M.B.A., MBChB
Ratings
MNMD NVO VRTX REGN SGEN ALNY
Quant Rating Score 2 3 2 4 3 2
Quant Rating Sell Neutral Sell Buy Neutral Sell
Trading
MNMD NVO VRTX REGN SGEN ALNY
Last Close $6.34 $113.24 $475.08 $922.79 $228.74 $281.49
High 52 $11.75 $146.91 $505.78 $1201.76 $228.9 $296.75
Low 52 $2.43 $96.21 $343 $779.89 $211.85 $143.31
Price vs. 52 Week High -46.04 % -22.92 % -6.07 % -23.21 % -0.07 % -5.14 %
Price vs. 52 Week Low 160.91 % 17.7 % 38.51 % 18.32 % 7.97 % 96.42 %
Total Return
MNMD NVO VRTX REGN SGEN ALNY
1 Month Return 12.61 % -4.04 % 1.13 % -11.86 % 0 % 1.97 %
3 Month Return -31.53 % -14.62 % -4.16 % -14.49 % 0 % 18.54 %
6 Month Return -32.77 % -12.36 % 18.14 % 2.14 % 0 % 87.71 %
9 Month Return 64.25 % -1.31 % 9.62 % -2.12 % 0 % 62.8 %
YTD Return 73.22 % 9.46 % 16.76 % 5.07 % 0 % 47.06 %
1 Year Return 147.66 % 17.23 % 31.2 % 18.32 % 7.49 % 85.43 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
MNMD NVO VRTX REGN SGEN ALNY
Dividend Yield Percentage (TTM) - 1.28 % - - - -
Dividend Paid and Capex Coverage Ration (TTM) -30427143.26 % 1.26 % -1.96 % 4.72 % -3.35 % 6.97 %
Dividend Per Share (TTM) - 0.21 % - - - -
Payout Ratio (TTM) - 46.71 % - - - -
Growth
MNMD NVO VRTX REGN SGEN ALNY
Asset Growth -26.74 % 30.35 % 25.23 % 13.23 % -1.21 % 7.99 %
Gross Profit Growth 1.89 % 32.32 % 9.25 % 6.49 % 22.93 % 74.75 %
Revenue Growth - 31.26 % 10.17 % 7.76 % 24.65 % 76.23 %
Revenue 3 Year - 90.51 % 59.87 % 55.67 % 91.84 % 241.5 %
Revenue 5 Year - 124.2 % 218.58 % 110.3 % 215.48 % 1865.57 %
Revenue 10 Year - 66.11 % 608.27 % 549.62 % 494.04 % 1810.11 %
EBIT Growth -41.51 % 37.11 % -12.94 % -14.6 % 10.13 % 64.06 %
Net Income Growth -102.56 % 50.71 % 8.96 % -8.87 % 9.51 % 61.08 %
Net Income 3 Yeari Growth Per Share -27.24 % 106.79 % 34.59 % 13.48 % -764.83 % 52.78 %
Net Income 5 Yeari Growth Per Share 16.87 % 133.86 % 70.33 % 74.02 % -276.93 % 53.44 %
Net Income 10 Yeari Growth Per Share -108.45 % 98.61 % 809.6 % 871.12 % -624.16 % -143.14 %
Operating Income Growth -41.51 % 37.11 % -12.94 % -14.6 % 10.13 % 64.06 %
Operating Cash Flow Growth (CFG) -28.37 % 38.06 % -14.35 % -8.39 % 9.07 % 119.24 %
Operating 3 Year CFG -23.63 % 118.29 % 9.63 % 76.95 % -148.34 % 115.59 %
Operating 5 Year CFG -199.66 % 163.51 % 174.78 % 125.17 % -195.86 % 114.91 %
Operating 10 Year CFG -178.91 % 150.92 % 6084.35 % 713.56 % -2622.09 % 174.76 %
EPS Growth -59.48 % 52.28 % 8.33 % -8.54 % 10.81 % 62.15 %
EPS Diluted Growth -59.48 % 52.37 % 8.35 % -9.03 % 10.81 % 62.15 %
Book Value Per Share -59.2 % 29 % 25.58 % 15.03 % -9.83 % -35.86 %
Share Holder 3 Year Equity Growth Per Share -53.32 % 75.22 % 104.06 % 137.56 % 33.92 % -119.99 %
Share Holder 5 Year Equity Growth Per Share -72.35 % 121.9 % 291.14 % 219.1 % 220.81 % -113.65 %
Share Holder 10 Year Equity Growth Per Share -44.53 % 49.62 % 1030.79 % 1286.9 % 691.19 % -140.22 %
Dividend Per Share Growth - 26.89 % - - - -
Dividend 3 Year Growth Per Share - 64.4 % - - - -
Dividend 5 Year Growth Per Share - 80.03 % - - - -
Dividend 10 Year Growth Per Share - 95.44 % - - - -
Debt Growth 19523.61 % 4.74 % 44.1 % 0.06 % -23.28 % 103.19 %
Free Cash Flow Growth -28.37 % 9.17 % -16.47 % -17.11 % 3.67 % 106.84 %
Updated On 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2022 31 Dec 2023
Profitability
MNMD NVO VRTX REGN SGEN ALNY
Gross Profit Margin TTM 56.24 % 84.53 % 86.43 % 86.08 % 75.4 % 87 %
Return on Assets TTM -38.05 % 24.34 % -2.43 % 11.98 % -20.64 % -1.82 %
Return on Equity TTM -71.33 % 87.5 % -2.91 % 16.3 % -28.06 % 47.92 %
Return on Capital Employed TTM -39.98 % 61.51 % -2.36 % 12.08 % -29.5 % 3.47 %
Net Income Per EBT TTM 100 % 79.6 % -228.18 % 94.21 % 101.53 % 118.22 %
EBT Per Ebit TTM 112.77 % 101.17 % -54.74 % 116.55 % 93.47 % -60.11 %
EBIT Per Revenue TTM -1870.26 % 43.26 % -3.8 % 29.18 % -34.37 % 4.38 %
Cash Flow To Debt Ratio TTM -299.99 % 202.13 % -101.14 % 205.21 % -475.96 % 15.08 %
Receivables Turnover TTM - 3.88 6.23 2.36 3.64 7.58
Payables Turnover TTM 0.72 1.34 4.27 3.34 2.52 4.12
Inventory Turnover TTM - 1.1 1.53 0.65 1.07 3.63
Fixed Asset Turnover TTM - 234.59 % 583 % 313.27 % 471.71 % 327.68 %
Asset Turnover TTM 1.8 % 69.85 % 51.28 % 37.38 % 63.3 % 58.47 %
Operating Cash Flow Per Share TTM -1.01 25.87 -3.66 37.65 -2.87 2.94
Free Cash Flow Per Share TTM -1.01 14.81 -5.52 29.68 -3.73 2.52
Cash Per Share TTM 338.1 % 1405.52 % 2245.45 % 9080.94 % 657.5 % 2071.01 %
Operating Cash Flow Sales Ratio TTM -1503.73 % 44.7 % -9.14 % 30.18 % -23.48 % 15.88 %
Free Cash Flow Operating Cash Flow Ratio TTM 100 % 57.25 % 151.04 % 78.82 % 129.82 % 85.66 %
Cash Flow Coverage Ratios TTM -299.99 % 202.13 % -101.14 % 205.21 % -475.96 % 15.08 %
Price To Free Cash Flows Ratio TTM -6.5 51.89 -86 31.18 -61.54 113.33
Price To Operating Cash Flows Ratio TTM -6.38 30.08 -129.89 24.51 -79.67 95.83
Price Cash Flow Ratio TTM -6.38 30.08 -129.89 24.51 -79.67 95.83
Income Statement (TTM)
MNMD NVO VRTX REGN SGEN ALNY
Revenue $0B $232.26B $9.84B $13.12B $1.96B $1.83B
Gross Profit $-0B $196.5B $8.58B $11.3B $1.55B $1.52B
Gross Profit Ratio 0% 84.6% 87.17% 86.16% 79.1% 83.02%
EBITDA $-0.09B $112.94B $3.93B $5.13B $-0.62B $-0.23B
Net Income $-0.1B $83.68B $3.62B $3.95B $-0.61B $-0.44B
EPS Diluted -2.44 18.62 13.89 34.77 -3.3 -3.52
Balance Sheet (MRQ)
MNMD NVO VRTX REGN SGEN ALNY
Long Term Debt $0.01B $20.53B $0.72B $2.7B $0.04B $2.34B
Total Liabilities $0.05B $207.93B $5.15B $7.11B $0.87B $4.05B
Total Equity $0.08B $106.56B $17.58B $25.97B $2.8B $-0.22B
Total Investments $0B $17.5B $3.45B $13.51B $1.42B $1.68B
Total Debt $0.01B $27.01B $0.81B $2.7B $0.04B $2.68B
Total Assets $0.12B $314.49B $22.73B $33.08B $3.67B $3.83B
Cash Flow Statement (TTM)
MNMD NVO VRTX REGN SGEN ALNY
Net Income $-0.1B $83.68B $3.62B $3.95B $-0.61B $-0.44B
Inventory $0B $-7.42B $-0.32B $-0.27B $-0.23B $0.02B
Dividends Paid $0B $-31.77B $0B $0B $0B $0B
Operating Cash Flow $-0.06B $108.91B $3.54B $4.59B $-0.45B $0.1B
Capital Expenditure $0B $-38.9B $-0.26B $-0.93B $-0.08B $-0.06B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 1.96
ABCL AbCellera Biologics Inc. 2.78
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 6.36
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 3.03
ABSI Absci Corporation 4.14
ABUS Arbutus Biopharma Corporation 3.94
ABVC ABVC BioPharma, Inc. 0.72
ABVX Abivax SA American Depositary Shares 10.49
ACAD ACADIA Pharmaceuticals Inc. 14.77
ACER Acer Therapeutics Inc. 0.9
ACET Adicet Bio, Inc. 1.36
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.02
ACHV Achieve Life Sciences, Inc. 4.73
ACIU AC Immune SA 2.97
ACLX Arcellx, Inc. 86.81
ACRV Acrivon Therapeutics, Inc. Common Stock 8.35
ACST Acasti Pharma Inc. 3.37
ETFs With Exposure to MNMD
Ticker ETF Name Weight Percentage Price
SCHB Schwab U.S. Broad Market ETF 0.000849762 22.43
SPDW SPDR Portfolio Developed World ex-US ETF 0.000003 35.96
SCHA Schwab U.S. Small-Cap ETF 0.011705 25.9
GWX SPDR S&P International Small Cap ETF 0.01 32.4
HDG ProShares Hedge Replication ETF 0.00257708 49.69
UWM ProShares Ultra Russell2000 0.00573584 42.82
XPH SPDR S&P Pharmaceuticals ETF 0.940007 46.41
IWC iShares Micro-Cap ETF 0.04534 126.53
FHLC Fidelity MSCI Health Care Index ETF 0.00501164 70.26
URTY ProShares UltraPro Russell2000 0.00295629 51.76
PILL Direxion Daily Pharmaceutical & Medical Bull 3X Shares ETF 0.691925 9.17
GSSC Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF 0 69.2119
VTWG Vanguard Russell 2000 Growth Index Fund 0.03 208.01
SPGM SPDR Portfolio MSCI Global Stock Market ETF 0.004037 64.16
EWSA.AS iShares MSCI World Small Cap ESG Enhanced UCITS ETF 0.01587 5.22
SWTSX Schwab Total Stock Market Index Fd Select Shs a Series of Schwab Capit 0.000692338 98.73
CUSS.L iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced UCITS ETF USD (Acc) 0.01377 537.19
SXRG.DE iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced UCITS ETF USD (Acc) 0.01302 494.5
PSIL AdvisorShares Psychedelics ETF 9.37 12.5087
CBUG.DE iShares MSCI World Small Cap ESG Enhanced UCITS ETF 0.01478 4.7985
CSUSS.MI iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced UCITS ETF USD (Acc) 0.01379 494.58
RSSL Global X Funds 0.02 87.2706
RFLR Innovator ETFs Trust 0.02 25.767
Unlock